A Study of JNJ-70033093 in Healthy Participants
NCT04448964
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
JNJ-70033093
Sponsor
Janssen Research & Development, LLC
Collaborators
[object Object]